Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 287-370-9 | CAS number: 85480-89-3
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was read across from EDTMP-xNa (CAS 22036-77-7) conducted according to an appropriate guideline, but not in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Buehler test
- GLP compliance:
- not specified
- Type of study:
- Buehler test
Test material
- Reference substance name:
- EDTMP-xNa
- IUPAC Name:
- EDTMP-xNa
- Reference substance name:
- [ethylenebis[nitrilobis(methylene)]]tetrakisphosphonic acid, sodium salt
- EC Number:
- 244-742-5
- EC Name:
- [ethylenebis[nitrilobis(methylene)]]tetrakisphosphonic acid, sodium salt
- Cas Number:
- 22036-77-7
- IUPAC Name:
- 22036-77-7
- Details on test material:
- - Name of test material (as cited in study report): Dequest 2046
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100% test material. Positive control induction in 80% ethanol, rechallenge in acetone as vehicle (concentration not reported).
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100% test material. Positive control induction in 80% ethanol, rechallenge in acetone as vehicle (concentration not reported).
- No. of animals per dose:
- The positive control group and the test material group consisted of 5 males and 5 females, and these animals were treated during the induction and challenge phases of this study. A third group was included which consisted of 3 males and 3 females, and these animals were treated only during the challenge phase to assess whether the challenge concentration was irritating.
- Details on study design:
- During the induction phase, the test material was applied for 6 hours and the skin was wiped free of any excess material. The treatment was repeated once a week for three weeks, for a total of three exposures. After a two week rest period, animals were treated during the first challenge phase at a new site with no previous application of test material.
- Challenge controls:
- Yes
- Positive control substance(s):
- yes
- Remarks:
- DNCB
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- rechallenge
- Group:
- positive control
- Dose level:
- acetone as vehicle
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- greater of the 24/48 hour score
- Remarks on result:
- other: Reading: rechallenge. Group: positive control. Dose level: acetone as vehicle. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: greater of the 24/48 hour score.
- Reading:
- rechallenge
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- 24/48 hour reading
- Remarks on result:
- other: Reading: rechallenge. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: 24/48 hour reading.
- Reading:
- 1st reading
- Group:
- other: challenge (irritation) control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 6
- Remarks on result:
- other: Reading: 1st reading. Group: other: challenge (irritation) control. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 6.0.
Any other information on results incl. tables
0.3 ml of the test material was applied at induction and challenge as a 100% solution.
Dequest 2046 is known to have 35.7% active salt content at pH 6 -8, and a specific gravity of 1.3 -1.36 g/ cm3.
The pKa of the salt at pH 7.3 is estimated to be 6. The conversion factor to determine the salt to acid equivalent for mass for EDTMP-6Na salt is 0.768.
Therefore, based on the known active salt proportion of the substance it is calculated that the at application to animal skin amount of active salt is 400 mg, and active acid 300 mg.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: not specified
- Conclusions:
- The test material was found not sensitising in a Buehler test, conducted according to an appropriate test protocol but not in compliance with GLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
